Singapore Medical Group Ltd
SGX:5OT
Balance Sheet
Balance Sheet Decomposition
Singapore Medical Group Ltd
Singapore Medical Group Ltd
Balance Sheet
Singapore Medical Group Ltd
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
8
|
5
|
7
|
6
|
8
|
21
|
20
|
27
|
26
|
27
|
|
| Cash |
8
|
0
|
0
|
0
|
8
|
21
|
20
|
27
|
26
|
27
|
|
| Cash Equivalents |
0
|
5
|
7
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
0
|
1
|
2
|
5
|
7
|
7
|
7
|
7
|
6
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
3
|
5
|
6
|
6
|
5
|
6
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
2
|
1
|
1
|
|
| Inventory |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Other Current Assets |
2
|
1
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
|
| Total Current Assets |
11
|
7
|
10
|
10
|
14
|
31
|
31
|
37
|
35
|
36
|
|
| PP&E Net |
4
|
3
|
2
|
3
|
7
|
14
|
14
|
21
|
17
|
20
|
|
| PP&E Gross |
4
|
3
|
2
|
0
|
0
|
14
|
14
|
21
|
17
|
20
|
|
| Accumulated Depreciation |
7
|
8
|
0
|
0
|
0
|
10
|
14
|
14
|
15
|
16
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
10
|
0
|
0
|
1
|
1
|
1
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
119
|
126
|
126
|
123
|
123
|
|
| Note Receivable |
1
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
3
|
2
|
|
| Long-Term Investments |
0
|
0
|
1
|
3
|
2
|
2
|
7
|
9
|
12
|
20
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
119
|
126
|
126
|
123
|
123
|
|
| Total Assets |
16
N/A
|
11
-33%
|
14
+29%
|
16
+19%
|
34
+113%
|
168
+387%
|
182
+8%
|
198
+9%
|
191
-4%
|
202
+6%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
2
|
2
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Accrued Liabilities |
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
9
|
|
| Short-Term Debt |
2
|
2
|
1
|
1
|
0
|
0
|
0
|
9
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
7
|
1
|
0
|
1
|
3
|
6
|
12
|
10
|
6
|
|
| Other Current Liabilities |
2
|
1
|
1
|
2
|
5
|
28
|
30
|
18
|
8
|
9
|
|
| Total Current Liabilities |
7
|
13
|
6
|
5
|
8
|
34
|
38
|
41
|
29
|
26
|
|
| Long-Term Debt |
5
|
0
|
0
|
0
|
2
|
8
|
12
|
11
|
7
|
8
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Minority Interest |
1
|
1
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
17
|
2
|
0
|
0
|
0
|
|
| Total Liabilities |
14
N/A
|
15
+7%
|
7
-55%
|
6
-13%
|
11
+90%
|
59
+432%
|
51
-14%
|
52
+1%
|
36
-29%
|
34
-7%
|
|
| Equity | |||||||||||
| Common Stock |
3
|
3
|
15
|
19
|
29
|
109
|
119
|
120
|
120
|
121
|
|
| Retained Earnings |
1
|
7
|
8
|
8
|
6
|
0
|
13
|
26
|
33
|
48
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
|
| Total Equity |
2
N/A
|
4
N/A
|
7
N/A
|
10
+49%
|
23
+126%
|
108
+365%
|
131
+21%
|
146
+12%
|
154
+6%
|
168
+9%
|
|
| Total Liabilities & Equity |
16
N/A
|
11
-33%
|
14
+29%
|
16
+19%
|
34
+113%
|
168
+387%
|
182
+8%
|
198
+9%
|
191
-4%
|
202
+6%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
154
|
154
|
251
|
276
|
311
|
459
|
459
|
483
|
483
|
486
|
|